Clinical trial
Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes
NCT00487240 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00487240 |
|---|---|
| Title | Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes |
| Official title | Comparison of Two Basal Insulin Analogs (Insulin Lispro Protamine Suspension and Insulin Detemir) in Basal-Bolus Therapy for Patients With Type 1 Diabetes |
| Acronym | IOOZ |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | Insulin Lispro Protamine Suspension, Insulin Levemir |
| Enrollment | 387 |
| Start date | Jun 1, 2007 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Jun 18, 2007 |
| Last update posted | Nov 4, 2010 |
| Countries | Argentina, Australia, Brazil, Greece, Hungary, Mexico, Romania, Russia, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: